Med Communications
Med Communications, headquartered in the United States, is a leading player in the healthcare communications industry, specialising in strategic medical writing, content development, and digital solutions. Founded in 2001, the company has established a strong presence across major operational regions, including North America and Europe. With a commitment to delivering high-quality, evidence-based communication, Med Communications offers unique services that cater to the needs of pharmaceutical and biotechnology companies. Their core offerings include medical education, regulatory writing, and promotional materials, all designed to enhance understanding and engagement within the medical community. Recognised for its innovative approach and dedication to excellence, Med Communications has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector. The company’s focus on collaboration and client satisfaction has solidified its reputation as a leader in medical communications.
DitchCarbon Score
How does Med Communications's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Med Communications's score of 6 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Med Communications's reported carbon emissions
Med Communications, Inc., headquartered in the United States, has set ambitious climate commitments despite not having specific carbon emissions data available. The company has committed to reducing its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 42% by the year 2030, using 2022 as the baseline year. This target has been validated through the Science Based Targets initiative (SBTi), which is particularly tailored for small and medium-sized enterprises (SMEs). Additionally, Med Communications aims to measure and reduce its Scope 3 emissions, demonstrating a comprehensive approach to tackling its overall carbon footprint. These commitments align with industry standards for climate action and reflect a proactive stance in addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Med Communications is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
